首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Structure-activity relationship studies of acridones as potential antipsoriatic agents. 2. Synthesis and antiproliferative activity of 10-substituted hydroxy-10H-acridin-9-ones against human keratinocyte growth.
【24h】

Structure-activity relationship studies of acridones as potential antipsoriatic agents. 2. Synthesis and antiproliferative activity of 10-substituted hydroxy-10H-acridin-9-ones against human keratinocyte growth.

机译:cri啶酮作为潜在的抗银屑病药物的构效关系研究。 2. 10-取代的羟基-10H-acridin-9-ones的合成及其抗人角质形成细胞生长的活性。

获取原文
获取原文并翻译 | 示例
           

摘要

A series of 10-substituted hydroxy-10H-acridin-9-ones were synthesized and studied as potential antipsoriatic agents. The antiproliferative activity of the novel derivatives, which can be considered as aza-analogues of the antipsoriatic drug anthralin, was determined using the human keratinocyte cell line HaCaT. Structure-activity relationships with respect to the nature of the N-substituent at the acridone scaffold were delineated. Release of lactate dehydrogenase (LDH) was used to exclude non-specific cytotoxic effects. As compared to anthralin, N-substitution of the acridone scaffold in the target compounds provided agents devoid of radical producing properties, which was documented by their ineffectiveness to interact with the free radical 2,2-diphenyl-1-picrylhydrazyl. This was in excellent agreement with the data obtained from the LDH assay in which the novel compounds did not induce membrane damage. Benzyl substitution at the 10-position yielded keratinocyte growth inhibitory activity in the low micromolar range. The most potent inhibitor of keratinocyte hyperproliferation was compound 8a having an N-methyl group and a 1,3-dihydroxy arrangement at the acridone scaffold, with an IC(50) value comparable to that of anthralin.
机译:合成了一系列10-取代的羟基-10H--啶9-9-酮,并研究了其作为潜在的抗银屑病药物。使用人角质形成细胞系HaCaT测定了可以被认为是抗银​​屑病药物anthralin的氮杂类似物的新型衍生物的抗增殖活性。描绘了在cri啶酮支架上相对于N-取代基的性质的构效关系。乳酸脱氢酶(LDH)的释放用于排除非特异性细胞毒性作用。与蒽醌相比,目标化合物中的cri啶酮支架的N取代提供了没有自由基产生特性的药物,这是由于它们与自由基2,2-二苯基-1-吡啶并肼基无效而证明的。这与从LDH测定中获得的数据非常一致,在所述LDH测定中,新化合物不引起膜损伤。在10位上的苄基取代产生了在低微摩尔范围内的角质形成细胞生长抑制活性。角质形成细胞过度增殖的最有效抑制剂是在compound啶酮支架上具有N-甲基和1,3-二羟基排列的化合物8a,其IC(50)值可与蒽林相当。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号